EVOGENE LTD Inactive Instrument
Evogene Ltd Share Price Other OTC
Equities
IL0011050551
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 20/06 | Nir Arbel Steps Down as Chief Product Officer of Evogene Ltd | CI |
| 23/05 | Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M | MT |
| Sales 2024 * | 1.5Cr 125.16Cr | Sales 2025 * | 2.58Cr 215.84Cr | Capitalization | 3.29Cr 275Cr |
|---|---|---|---|---|---|
| Net income 2024 * | -2.2Cr -183.69Cr | Net income 2025 * | -1.9Cr -158.64Cr | EV / Sales 2024 * | 2.2 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.27 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on Evogene Ltd
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01/02/01 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 01/22/01 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 17/21/17 |
Sarit Firon
CHM | Chairman | 58 | 11/16/11 |
Leon Recanati
BRD | Director/Board Member | 76 | 01/05/01 |
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Calendar
07/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 4.66TCr | |
| +45.38% | 4.17TCr | |
| +0.69% | 4.12TCr | |
| +30.52% | 3.24TCr | |
| +22.30% | 2.82TCr | |
| -6.35% | 2.81TCr | |
| +49.25% | 1.45TCr | |
| +49.18% | 1.37TCr | |
| +3.45% | 1.22TCr |
